ThomasReeveChaunceyMD

Oncology • Seattle, WA

Associate Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Chauncey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Chauncey's full profile

Already have an account?

Office
1660 S Columbian Way
Marrow Transplant Unit (111)
Seattle, WA 98108
Phone+1 206-764-2969

Fax+1 206-764-2851
Is this information wrong?

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1988 - 1992
University of WashingtonResidency, Internal Medicine, 1985 - 1988
Rush Medical College of Rush University Medical CenterClass of 1985

Certifications & Licensure

WA State Medical License 1986 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2000 Feb 01
Completed
Phase 2
Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma Start of enrollment: 1999 Sep 01
Completed
Phase 1, Phase 2
S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia Start of enrollment: 2001 Aug 01
Completed
Phase 2
S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2004 Jul 01
Completed
Phase 2
Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant Start of enrollment: 2003 May 01
Completed
Phase 1, Phase 2
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer Start of enrollment: 2004 Apr 01
Completed
Phase 2
Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant Start of enrollment: 2003 May 01
Completed
Phase 2
Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2004 Dec 01
Completed
Phase 2
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma Start of enrollment: 2005 Jul 01
Completed
Phase 3
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders Start of enrollment: 2006 Jan 01
Completed
Phase 2
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease Start of enrollment: 2005 Nov 18
Active, not recruiting
Phase 2
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 2008 Jun 25
Completed
Phase 2
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant Start of enrollment: 2010 Nov 01
Completed
Phase 3
Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant Start of enrollment: 2010 Dec 01
Completed
Phase 2
Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant Start of enrollment: 2011 Jan 25
Completed
Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network.
Christina M Termini, Anna Moseley, Megan Othus, Frederick R Appelbaum, Thomas R Chauncey, Harry P Erba, Min Fang, Stanley C Lee, Jasmine Naru, Era L Pogosova-Agadjanya...> ;Haematologica. 2023 Nov 1
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients.
Era L Pogosova-Agadjanyan, Xing Hua, Megan Othus, Frederick R Appelbaum, Thomas R Chauncey, Harry P Erba, Matthew P Fitzgibbon, Isaac C Jenkins, Min Fang, Stanley C Le...> ;Biomarker Research. 2023 Mar 16
1 citations
Androgens and estrogens predict sexual function after autologous hematopoietic stem cell transplant in men.
Lindsey J. Anderson, Dorota Migula, Rebecca Abay, Stephanie Crabtree, Solomon A. Graf, Alvin M. Matsumoto, Thomas R. Chauncey, Jose M. Garcia> ;Andrology. 2021 Oct 8
Long-term Outcomes with Nonmyeloablative HLA-Identical Related Hematopoietic Cell Transplantation Using Tacrolimus and Mycophenolate Mofetil for Graft-versus-Host Dise...
Masumi Ueda Oshima, Barry E. Storer, Huiying Qiu, Thomas R. Chauncey, Julie Asch, Michael Boyer, Luisa Giaccone, Mary E.D. Flowers, Marco Mielcarek, Rainer Storb, Davi...> ;Transplantation and Cellular Therapy. 2021 Feb 1
2 citations
Autologous hematopoietic transplantation following COVID-19 infection.
Marthilde Brzycki, Robert E. Richard, Nicholas Burwick, Solomon A. Graf, Craig O'Brien, Daniel Wu, Thomas R. Chauncey> ;Clinical Case Reports. 2021 Jan 3
9 citations
Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell Lymphoma.
Solomon A. Graf, Ryan D. Cassaday, Karolyn Morris, Jenna M. Voutsinas, Qian Vicky Wu, Sanaz Behnia, Ryan C. Lynch, Elizabeth F. Krakow, Heather Rasmussen, Thomas R. Ch...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Mar 1
11 citations
Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)
Heather Klocke, Zhao Ming Dong, Craig O'Brien, Nicholas Burwick, Robert E. Richard, Daniel Y Wu, Thomas R. Chauncey, Solomon A. Graf> ;Case Reports in Hematology. 2020 Oct 10
14 citations
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen mismatched donors
Brian Kornblit, Barry E. Storer, Niels Smedegaard Andersen, Michael B. Maris, Thomas R. Chauncey, Effie W. Petersdorf, Ann E. Woolfrey, Mary Ed Flowers, Rainer Storb, ...> ;Blood. 2020 Sep 24
19 citations
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Jason P. Cooper, Barry E. Storer, Noa Granot, Boglarka Gyurkocza, Mohamed L. Sorror, Thomas R. Chauncey, Judith A. Shizuru, Georg Franke, Michael B. Maris, Michael Boy...> ;Haematologica. 2020 Jun 4
1 citations
Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience.
Aaron Wu, Solomon A. Graf, Nicholas Burwick, Jonathan E. Grim, Zhao Ming Dong, Robert E. Richard, Thomas R. Chauncey> ;Blood Research. 2020 Mar 31
10 citations
Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience.
Mazyar Shadman, David G. Maloney, Barry E. Storer, Brenda M. Sandmaier, Thomas R. Chauncey, Niels Smedegaard Andersen, Dietger Niederwieser, Judith A. Shizuru, Benedet...> ;Bone Marrow Transplantation. 2020 Jan 1
5 citations
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia.
Elizabeth F. Krakow, Boglarka Gyurkocza, Barry E. Storer, Thomas R. Chauncey, Jeannine S. McCune, Jerald P. Radich, Michelle E. Bouvier, Elihu H. Estey, Rainer Storb, ...> ;American Journal of Hematology. 2020 Jan 1
11 citations
Assessing Cachexia Acutely after Autologous Stem Cell Transplant.
Lindsey J. Anderson, Chelsea Yin, Raul Burciaga, Stephanie Crabtree, Dorota Migula, Kelsey Geiss-Wessel, Haiming M. Liu, Solomon A. Graf, Thomas R. Chauncey, Jose M. G...> ;Cancers. 2019 Sep 4
64 citations
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative ha...
Brenda M. Sandmaier, Brian Kornblit, Barry E. Storer, Gitte Olesen, Michael B. Maris, Amelia Langston, Jonathan A. Gutman, Soeren Lykke Petersen, Thomas R. Chauncey, W...> ;The Lancet. Haematology. 2019 Jun 24
13 citations
Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myel...
Federico Monaco, Bart L. Scott, Thomas R. Chauncey, Finn Bo Petersen, Barry E. Storer, Frédéric Baron, Mary E.D. Flowers, H. Joachim Deeg, David G. Maloney, Rainer Sto...> ;Haematologica. 2019 Jun 1
21 citations
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.
Enrico Maffini, Barry E. Storer, Brenda M. Sandmaier, Benedetto Bruno, Firoozeh Sahebi, Judith A. Shizuru, Thomas R. Chauncey, Parameswaran Hari, Thoralf Lange, Michae...> ;Haematologica. 2019 Feb 1
10 citations
Second allogeneic hematopoietic cell transplantation for relapse after first allografts.
Boglarka Gyurkocza, Rainer Storb, Thomas R. Chauncey, David G. Maloney, Barry E. Storer, Brenda M. Sandmaier> ;Leukemia & Lymphoma. 2019 Jan 22
17 citations
Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies.
Abby Statler, Megan Othus, Harry P. Erba, Thomas R. Chauncey, Jerald P. Radich, Steven Coutre, Anjali S. Advani, Sucha Nand, Farhad Ravandi, Sudipto Mukherjee, Mikkael...> ;Blood. 2018 Jun 21
5 citations
Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report
Era L. Pogosova-Agadjanyan, Anna Moseley, Megan Othus, Frederick R. Appelbaum, Thomas R. Chauncey, I-Ming L. Chen, Harry P. Erba, John E. Godwin, Min Fang, Kenneth J. ...> ;Biopreservation and Biobanking. 2017 Nov 27
6 citations
Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial
Merav Bar, Mary E.D. Flowers, Barry E. Storer, Thomas R. Chauncey, Michael A. Pulsipher, Monica S. Thakar, Wolfgang Bethge, Rainer Storb, David G. Maloney, Brenda M. S...> ;Biology of Blood and Marrow Transplantation. 2018 Feb 1
10 citations
CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
Frederick L. Locke, Joseph Pidala, Barry E. Storer, Paul J. Martin, Michael A. Pulsipher, Thomas R. Chauncey, Niels Jacobsen, Nicolaus Kröger, Irwin Walker, Susan Ligh...> ;Biology of Blood and Marrow Transplantation. 2017 Mar 1
17 citations
Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.
Solomon A. Graf, Jennifer E. Vaughn, Thomas R. Chauncey, Barry E. Storer, Ajay K. Gopal, Leona Holmberg, Jeannine S. McCune, William I. Bensinger, David G. Maloney, Ol...> ;Biology of Blood and Marrow Transplantation. 2016 Sep 1
36 citations
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Andrew J. Cowan, Philip A. Stevenson, Ryan D. Cassaday, Solomon A. Graf, Jonathan R. Fromm, David Wu, Leona Holmberg, Brian G. Till, Thomas R. Chauncey, Stephen D. Smi...> ;Biology of Blood and Marrow Transplantation. 2016 Feb 1
20 citations
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT.
William I. Bensinger, Pamela S. Becker, Ted Gooley, Thomas R. Chauncey, David G. Maloney, Ajay K. Gopal, Damian J. Green, Oliver W. Press, Michael Lill, Jainulabdeen J...> ;Bone Marrow Transplantation. 2016 Jan 1
10 citations
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma
Ryan D. Cassaday, Philip A. Stevenson, Ted Gooley, Thomas R. Chauncey, John M. Pagel, Joseph G. Rajendran, Brian G. Till, Mary Philip, Johnnie J. Orozco, William I. Be...> ;British Journal of Haematology. 2015 Dec 1
Join now to see all

Journal Articles

Long Term Follow-up of Tandem Autologous-Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma
Parameswaran Hari, Brenda M Sandmaier, Pamela S Becker, Leona Holmberg, Damian J Green, Peter A McSweeney, David G Maloney, Thomas R Chauncey, Haematologica

Abstracts/Posters

Development and Performance of Risk Stratification Models for AML Patients Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG Report
Thomas R. Chauncey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Ibrutinib in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Final Results from a Prospective Phase II Study
Thomas R. Chauncey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell ...
Thomas R. Chauncey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019